GlassScriptPhysician profile
Jiyeon Shin
NPI 1275741563
$1,559.74
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.66 · 2020: $24.70 · 2021: $644 · 2022: $618 · 2023: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $193.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $316.20 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Aspira Women'S Health INC | $265.85 | 2021-2023 | Ova1 |
| Coopersurgical, INC. | $168.66 | 2021-2023 | Paragard T 380a |
| Mayne Pharma Commercial LLC | $143.87 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.80 | 2021-2023 | |
| Therapeuticsmd, INC. | $107.13 | 2020-2022 | |
| Organon LLC | $103.74 | 2021-2023 | Nexplanon |
| Exeltis, USA INC. | $76.59 | 2022-2023 | Slynd |
| Myovant Sciences INC. | $50.51 | 2021-2022 | |
| Pfizer INC. | $40.56 | 2021-2022 | |
| Evofem Biosciences, INC. | $29.64 | 2021-2022 | |
| Ethicon US, LLC | $25.29 | 2021 | |
| Hologic Sales and Service, LLC | $24.70 | 2019 | |
| Amag Pharmaceuticals, INC. | $21.71 | 2019 | |
| Astellas Pharma US INC | $19.72 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.20 | 2021 | |
| Sage Therapeutics, LLC | $14.17 | 2021 | |
| Minerva Surgical, INC | $13.40 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jiyeon Shin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.